Chemoinformaics analysis of 12-METHYL-13-TRIDECANOLIDE
| Molecular Weight | 226.36 | nRot | 0 |
| Heavy Atom Molecular Weight | 200.152 | nRig | 15 |
| Exact Molecular Weight | 226.193 | nRing | 1 |
| Solubility: LogS | -4.987 | nHRing | 1 |
| Solubility: LogP | 5.381 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 42.3206 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.582 |
| Synth | 2.941 |
| Natural Product Likeliness | 1.02 |
| NR-PPAR-gamma | 0.048 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.519 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.693 |
| MDCK | 0.0000235 |
| BBB | 0.525 |
| PPB | 0.963694 |
| VDSS | 0.731 |
| FU | 0.0268274 |
| CYP1A2-inh | 0.909 |
| CYP1A2-sub | 0.199 |
| CYP2c19-inh | 0.576 |
| CYP2c19-sub | 0.069 |
| CYP2c9-inh | 0.398 |
| CYP2c9-sub | 0.84 |
| CYP2d6-inh | 0.054 |
| CYP2d6-sub | 0.096 |
| CYP3a4-inh | 0.258 |
| CYP3a4-sub | 0.11 |
| CL | 6.891 |
| T12 | 0.511 |
| hERG | 0.129 |
| Ames | 0.02 |
| ROA | 0.047 |
| SkinSen | 0.958 |
| Carcinogencity | 0.182 |
| EI | 0.967 |
| Respiratory | 0.742 |
| NR-Aromatase | 0.034 |
| Antiviral | Yes |
| Prediction | 0.79459 |